Northern Trust
STLN

Northern Trust’s Starling Oncology STLN Stock Holding History

Northern Trust’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.21M Buy
591,534
+33,079
+6% +$139K ﹤0.01% 2881
2026
Q1 		$1.71M Buy
558,455
+59,211
+12% +$182K ﹤0.01% 3058
2025
Q4 		$1.78M Buy
499,244
+34,552
+7% +$128K ﹤0.01% 3065
2025
Q3 		$1.62M Buy
464,692
+53,335
+13% +$183K ﹤0.01% 3145
2025
Q2 		$843K Buy
411,357
+334,364
+434% +$836K ﹤0.01% 3470
2025
Q1 		$87.8K Buy
76,993
+12,091
+19% +$9.36K ﹤0.01% 4144
2024
Q4 		$20.1K Hold
64,902
– – ﹤0.01% 4376
2024
Q3 		$21.2K Hold
64,902
– – ﹤0.01% 4331
2024
Q2 		$29.9K Sell
64,902
-94
-0.1% -$80 ﹤0.01% 4288
2024
Q1 		$103K Buy
64,996
+1,053
+2% +$2K ﹤0.01% 4077
2023
Q4 		$130K Buy
63,943
+19,355
+43% +$33.6K ﹤0.01% 4045
2023
Q3 		$62.4K Sell
44,588
-3,522
-7% -$3.65K ﹤0.01% 4120
2023
Q2 		$26.5K Sell
48,110
-214,268
-82% -$113K ﹤0.01% 4350
2023
Q1 		$178K Buy
262,378
+4,983
+2% +$6.36K ﹤0.01% 3905
2022
Q4 		$425K Buy
257,395
+2,046
+0.8% +$5.74K ﹤0.01% 3560
2022
Q3 		$1.18M Buy
255,349
+111,428
+77% +$655K ﹤0.01% 3257
2022
Q2 		$729K Buy
143,921
+125,856
+697% +$917K ﹤0.01% 3422
2022
Q1 		$129K Buy
+18,065
New +$122K ﹤0.01% 4273

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust's STLN Position: Q2 2026 in Review

Northern Trust increased its Starling Oncology (STLN) stake by 5.9% in Q2 2026, buying an estimated $139K and bringing the position to 591,534 shares worth $3.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2881.

Northern Trust first reported a position in STLN in Q1 2022 and has held it in 18 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Northern Trust held 591,534 shares of Starling Oncology worth $3.21M as of Q2 2026.
  • Northern Trust bought 33,079 Starling Oncology shares in Q2 2026, an estimated $139K.
  • Starling Oncology made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2881 holding.
  • Northern Trust first reported a position in Starling Oncology in Q1 2022 and has held it in 18 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.